Skip to main content

During the 2018 National Rare Diseases Plan (PNMR3), the CHU Caen Normandie treatment center was renewed as a constituent site of the Willebrand Disease Reference Center ( CRMW )

  • Activity

    Supported

    The Haemorrhagic Diseases Treatment Center of CHU Caen Normandie ( CRTH ) provides comprehensive care for people with haemorrhagic diseases.

    The Caen center provides comprehensive care for people with von Willebrand disease:

    • Clinico-biological diagnosis
    • Clinical and biological follow-up
    • Therapeutic Education Activities
    • Drafting of treatment protocol

    The Caen center also provides training and teaching activities on Willebrand's disease and clinical and basic research activities (therapeutic trials, PHRC , etc.) .